{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of US-Guided Steroid Injections in de Quervain Disease"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "50 patients with de Quervain disease and complete intracompartmental septum were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "50 patients with de Quervain disease and complete intracompartmental septum"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive US-guided injections in both subcompartments (n = 25) or the EPB subcompartment alone (n = 25)"
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to compare the efficacy and safety of US-guided steroid injections"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pain reduction measured by VAS score at 6 weeks"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "50 patients with de Quervain disease and complete intracompartmental septum were randomised"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "mean difference -0.08, 95% CI -4.08 to 3.91; p = 0.97"
      },
      "Harms": {
        "score": 1,
        "evidence": "Skin hypopigmentation was less frequent in the EPB group (33% vs. 67%; odds ratio 0.25, 95% CI 0.08 to 0.83; p = 0.02)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}